EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Australian researcher's perspectives on the Australian industry‐led moratorium on genetic tests in life insurance

Tatiane Yanes, Marisa Blencoe, Antonia Howard, Jane Tiller, Courtney Wallingford, Margaret Otlowski, Louise Keogh, Paul Lacaze, Aideen McInerney-Leo iD

American Journal of Medical Genetics Part A · 2024-06 · 194 (6)

DOI: 10.1002/ajmg.a.63565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 14.02.2024. Verfasst von Tatiane Yanes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Genetic Testing, Insurance, Life, Research Personnel. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government's Medical Research Future Fund Genomics Health Futures Mission, National Health and Medical Research Council, Australian Government Research Training Program Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fear of insurance discrimination can inhibit genetic research participation. In 2019, an industry‐led partial moratorium on using genetic results in Australian life insurance underwriting was introduced. This mixed‐methods study used online surveys ( n = 59 participants) and semi‐structured interviews ( n = 22 participants) to capture researchers’ perceptions about the moratorium. 66% ( n = 39/59) were aware of the moratorium before the survey. Of researchers returning genetic results, 56% ( n = 22/39) reported that insurance implications were mentioned in consent forms, but a minority reported updating consent forms post‐moratorium ( n = 13/39, 33%). Most researchers reported that concerns regarding life insurers utilizing research results inhibited recruitment (35/59, 59%), and few perceived that the moratorium positively influenced participation ( n = 9/39, 23%). These findings were supported by qualitative findings which revealed that genetic discrimination concerns were a major issue for some individuals, though these concerns could be eclipsed by the promise of a diagnosis through research participation. The majority thought a regulatory solution should be permanent ( n = 34/51, 67%), have financial limits of at least ≥1,000,000 AUD (37/51, 73%), and involve government oversight/legislation ( n = 44/51, 86%). In an era where an increasing number of research studies involve genomics as a primary or secondary objective, it is crucial that we have regulatory solutions to address participants’ hesitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingInsurance, LifeResearch PersonnelHumansAustraliaMaleFemaleSurveys and QuestionnairesAdultMiddle Aged

Stichwörter der Autor:innen

genetic discriminationgenetic researchgenetic testinglife insurancemoratorium

Autor:innen und Institutionen

  • Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Queensland, Australia.
  • Graduate School of Health, University of Technology Sydney, Sydney, New South Wales, Australia.
  • School of Public Health and Preventive Medicine, Monash University Faculty of Medicine Nursing and Health Sciences, Melbourne, Victoria, Australia.
  • University of Tasmania, Hobart, Tasmania, Australia.
  • Centre for Health Equity, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.

ORCID-Profile: Aideen McInerney-Leo

Förderung

  • Australian Government's Medical Research Future Fund Genomics Health Futures Mission
  • National Health and Medical Research Council
  • Australian Government Research Training Program Scholarship
  • University of Queensland Faculty of Medicine Fellowship

Zitieren

APA

Yanes, T., Blencoe, M., Howard, A., Tiller, J., Wallingford, C., Otlowski, M., Keogh, L., Lacaze, P., & McInerney-Leo, A. (2024). Australian researcher's perspectives on the Australian industry‐led moratorium on genetic tests in life insurance. American Journal of Medical Genetics Part A, 194(6). https://doi.org/10.1002/ajmg.a.63565

Vancouver

Yanes T, Blencoe M, Howard A, Tiller J, Wallingford C, Otlowski M, et al. Australian researcher's perspectives on the Australian industry‐led moratorium on genetic tests in life insurance. American Journal of Medical Genetics Part A. 2024;194(6). doi:10.1002/ajmg.a.63565

BibTeX
@article{Yanes2024,
  author = {Yanes, Tatiane and Blencoe, Marisa and Howard, Antonia and Tiller, Jane and Wallingford, Courtney and Otlowski, Margaret and Keogh, Louise and Lacaze, Paul and McInerney-Leo, Aideen},
  title = {Australian researcher's perspectives on the Australian industry‐led moratorium on genetic tests in life insurance},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  volume = {194},
  number = {6},
  doi = {10.1002/ajmg.a.63565}
}
Kostenlos starten →